Mesenchymal stromal cells as treatment for chronic GVHD
Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success
The EBMT activity survey 2008: impact of team size, team density and new trends
Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY
Co-infusion of ex vivo- expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation
Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation
Autologous purified peripheral blood SCT in childhood low-risk relapsed ALL
The care of critically ill children after hematopoietic SCT: a North American survey
Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trial
A single-nucleotide polymorphism of the Fcc receptor type IIIA gene in the recipient predicts transplant outcomes after HLA fully matched unrelated BMT for myeloid malignancies
Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experience
Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy
Unrelated cord blood transplantation after myeloablative conditioning in adults with advanced myelodysplastic syndromes
Comparison of outcomes after auto-SCT for patients with relapsed diffuse large B-cell lymphoma according to previous therapy with rituximab
Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome
Toxoplasmosis in allo-SCT patients: risk factors and outcomes at a transplantation center with a low incidence
Bone marrow mononuclear cells versus G-CSF-mobilized peripheral blood mononuclear cells for treatment of lower limb ASO: pooled analysis for long-term prognosis
The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia
Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization
A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT
Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated
Addition of plerixafor to a chemotherapy plus G-CSF mobilization in hard-to-mobilize patients
Voriconazole for both successful treatment of disseminated Trichosporon asahii infection and subsequent cord blood transplantation in an infant with acute myelogenous leukemia
Prophylactic oseltamivir treatment for prevention of donor-recipient influenza A H1N1 virus transmission does not compromise stem cell mobilization or engraftment
AMD3100 for urgent PBSC mobilization and allogeneic transplantation from a normal donor after failed marrow harvest
Parvovirus B19 as an etiological agent of acute pleuro-pericarditis
Bortezomib and donor lymphocyte infusion in multiple myeloma relapsed after allo-SCT does not result in durable remissions
Bortezomib and donor lymphocyte infusion in multiple myeloma relapsed after allo-SCT does not result in durable remissions